FTC chief predicts ban on pay-for-delay deals will pass this year

03/19/2010 | Wall Street Journal, The

Federal Trade Commission Chairman Jon Leibowitz said he thinks a proposal to prohibit pay-for-delay deals between brand-name and generic-drug companies will pass this year even if the measure gets dropped from the health reform bill. Leibowitz said bipartisan support is building for the proposal, which would restrict patent settlements that prevent the early launch of generic medicines.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID